TRELAGET
TRELAGLIPTIN · by GETZ
Composition
Tab 50 mg/100 mg: Trelagliptin 50 mg/100 mg
Indications & Dosage
Type 2 diabetes mellitus as monotherapy or in combination to achieve adequate glycaemic control: Adults: 100 mg once a week. Elderly: 50-100 mg once a week.
Contraindications
Diabetic ketoacidosis, Hypoglycemia, Congestive heart failure, Acute Pancreatitis.
Precautions
Immuno-compromised patients, elderly. Acute pancreatitis has been associated with DPP-4 inhibitors patients should be observed carefully for signs and symptoms of pancreatitis (discontinue).
Interactions
Potent CYP3A4/5 inducers.
Pregnancy
Avoid unless essential.
Lactation
Caution advised, avoid
Side Effects
Dizziness, dyspepsia, fatigue, gastritis, gastroenteritis, vomiting, headache, hypoglycaemia, myalgia, nasopharyngitis, peripheral oedema, sinusitis, respiratory and urinary tract infection, anaphylaxis, arthralgia, dyslipidaemia, erectile dysfunction, hypersensitivity reactions, hyper triglyceridaemia, pancreatitis (discontinue), rash, Pruritis, Atrial Fibrillation, Nasopharyngitis, ALT increased, AST increased.